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ABSTRACT

Methylene blue (MB) with a 10-N-carbamoyl linkage was discovered and developed as a
multifunctional far-red (660 nm) photocleavable ligand capable of rendering a series of MB
conjugated compounds with off-to-on fluorescence switch properties through the controlled
release of MB. The released MB was successfully demonstrated to be an effective
photosensitizer, imaging probe, and therapeutic agent. The complete release of MB was achieved
with a cumulative light dose of 15 J/cm2. The photosensitivity was demonstrated to be dependent
on the type of chemical bond at 10-N of the phenothiazine ring which links MB to a side group.
Specifically, the urea bond-based derivatives could undergo a complete photolysis, while those
with carbamate bond showed negligible photolysis. The released MB was subsequently utilized
as fluorescent imaging dye, and photosensitizer demonstrated through the significant reduction in
cell viability compare to un-irradiated samples (16.1 ± 16.7 % and 72.8±0.33 %, respectively).
The 10-N carbamoyl linkage MB was also reported to be a hydroxyl radical triggered
cleavable ligand. Probed by this platform, hemoproteins were demonstrated to be a much more
efficient Fenton’s catalyst than commonly used inorganic Fe(II) salts. The applicability of this
ligand was demonstrated through the capability of being triggered by elevated reactive oxygen
species levels at diseased tissue, with malaria-parasitized erythrocytes as an in vitro model. The
conjugation between antimalarial agent primaquine (PQ), and MB moiety, was suggested to be
preferentially activated by malaria parasite. Subsequently, the hybrid drug MB-PQ successfully
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demonstrated a relatively low IC50 (<30 nM) towards malaria, and 2-5 times higher selectivity
index compare to the parent compounds.
The applicability of MB ligand was also utilized in the synthesis of liposome-forming
material for drug delivery purposes. The MB conjugated phospholipid demonstrated the
capability to form stimuli-responsive liposome. Specifically, upon irradiating with UV light or
the treatment with ROS, the liposome structure was disrupted leading to the release of the
payload.

iii

PREFACE

The most exciting phrase to hear in science, the one that heralds new discoveries, is not
“Eureka!” (I found it!) but “That’s funny …”
Isaac Asimov

I already knew about this quote prior to my Ph.D. program at Ole Miss, however at the
time it was just a brainy quote like million other quotes found online. Until I experienced it
myself, to the fullest extent. The first chapter of this thesis started out with an accident and an
interesting observation, involving the laboratory light was not turned off for 2 days straight. This
incident, eventually resulted in my finding about a novel light-sensitive ligand. The course of
the second chapter is less linear, although not less interesting. In 2018, I was thrilled to find out a
novel property of our synthesized compound. Unfortunately, excitement soon turned into bitter
disappointment a few months later, when relatively similar findings was published. In 2020, after
having completed the other projects, I turned back to this old one with the intention to salvage
whatever data I can to make up for my Ph.D. thesis. To my surprise, some unexpected weirdly
looking data showed up and persisted even after 6-7 attempts to repeat the experiments to get
“nicer” looking data. Then the utmost joyfulness came when further data suggested your result is
every bit as novel as the published research.
Huy M. Dao, Oxford MS, 2021
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CHAPTER I
INTRODUCTION
1.1. Methylene Blue physicochemical and therapeutic properties
Methylene blue (MB), a simple medication and common dye well tolerable by human
body, was first prepared in 1876 by Heinrich Caro. MB is being used regularly in multiple
biomedical applications such as redox indicator and especially biological staining. MB is also
listed on the World Health Organization’s list of Essential Medicines, possibly due to its
versatile therapeutic effects, utilized in the treatment of methemoglobinemia, urinary tract
infection, potent photodynamic sensitizer, Alzheimer, and recently revisited as combination
therapy for antimalarial treatment. More interestingly, despite being a 150-year-old synthetic
compound, new properties and applications related to the phenothiazine ring, the main
component of MB, are lately still keep being reported. In that regard, this dissertation, which
comprises of three chapters, reported two novel properties of the 10-N carbamoyl linked MB as a
stimuli-sensitive moiety. Specifically, MB moiety was discovered as a far-red photocleavable
ligand, and investigated for the syntheses of light-activated theranostic agents. MB moiety was
also found to be sensitive to hydroxyl radical, which combined with proven sensitivity toward
hypochloric acid, was utilized for the syntheses of reactive oxygen species hybrid drug and drug
delivery materials.
Methylene blue has a strong optical property, in which concentration in the low
micromolarity range is able to produce a strong blue color detectable by naked eyes. As a result,
MB is commonly used as a general biological stain for the acidic cell parts such as the nucleus.
1

Additionally, MB is considered a borderline near infrared fluorescent dye with 660 nm
excitation wavelength and 690 nm emission wavelength, desirable for the in vivo imaging. MB is
also a potent photosensitizer, utilized in the photodynamic therapy to generate singlet oxygen
upon irradiation with 660 nm far-red light. The 1O2 cytotoxicity has been consistently proven in
multiple disease model such as basal cell carcinoma, melanoma, virus and fungal infections.
Interestingly, all property was effectively switched off upon the modification or caging at the 10N position and can be completely restored. There are two approaches for the caging – uncaging
process, including (1) stimuli sensitive and uncaging at the 10-N position is conferred by a
separated moiety and (2) stimuli sensitive lays within the MB moiety itself (Table 1).

MB
itself

Separate
d moiety

Table 1. List of MB based stimuli sensitive probes and theranostic agents
Stimuli
Sensitive moiety
References
1
Nitroreductase
Para-nitrobenzyl
2
Tyrosinase
4-(2-aminoethyl) phenol
3
Fluoride ion
Silyether
4
UV light
Ortho-nitrobenzyl
5–11
HOCl
10-N carbamoyl MB
12
Far-red light
10-N carbamoyl MB
13
Hydroxyl radical
10-N carbamoyl MB
1.2. Photochemistry
One of the ultimate goal of the design of drug delivery system is to deliver the therapeutic
agent to the targeted tissues as premature drug release during circulation may lead to insufficient
concentration at the desirable pathological tissues and adverse effect to healthy cells. Hence,
stimuli-responsive drug delivery systems are designed to release the payload under the influence
of a particular stimulus. Although the concepts have been consistently demonstrated in vitro, the
clinical translational is greatly hindered due to the considerable inter-individual variability. As a
result, external stimuli such as magnetic field, ultrasound, and particularly light are considered as
attractive approaches due to ease and better spatio-temporal control.

2

Among the photo-absorption materials, most materials described in the literature rely on
one-photon excitation by UV light, primarily due to the potency of the UV photon with enough
energy to break, isomerize, and rearrange a variety of molecules. However, although the
photochemistry is often rapid and efficient, many endogenous molecules both absorb and are
degraded by UV light. Hence, the clinical application of such systems are limited due to the poor
tissue penetration, and potentially greater cell damage. Far-red and near infrared light, with a
wavelength ranging from 650 to 1000 nm is considered desirable due to the good tissue
penetration. This is considered the window region for in vivo imaging due to low extinction
coefficient of the ubiquitous hemoglobin chromophores. Additionally, due to the inherently low
energy that the NIR photon carries with, NIR light is also regarded as less harmful to cells than
UV light. In summary, far-red and NIR-responsive systems are potential carriers for drug
delivery in targeted site for clinical application. However, the aforementioned advantage also
carries an inherent disadvantage, in which the energy of the photon is too low to exert a
significant change. The effect of far-red and NIR light includes photothermal effect, leading to
an increase in temperature at the irradiated site. The elevated temperature can cause disruption in
the integrity of the drug delivery system leading to the release of payload. Other mechanisms
involved two-photon conversion and up conversion nanoparticles. However, there are very few
known photoresponsive chromophores capable of undergoing drastic changes such as bond
cleavage or isomerization that absorbs this low energy light directly. Therefore, a moiety that is
NIR-responsive is highly desirable.
1.3. Reactive oxygen species
Reactive oxygen species (ROS) are highly reactive ions and free radicals, including
superoxide, hydroxyl radical, hypochlorite ion, hydrogen peroxide, and singlet oxygen. Produced
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mainly by mitochondria, endoplasmic reticulum and NADPH oxidase, those ROS play a vital
role in both physiological and pathological functions. In general, at low levels ROS regulate cell
signaling pathway and promote cell proliferation whereas high levels of ROS induce the nonspecific damage of proteins, lipids, bacteria and pathogens

14

. This abnormal biochemical

alteration in the disease sites has inspired researchers to exploit unbalanced ROS levels for
developing target-specific molecular probes, prodrugs, and drug delivery systems.
1.4. Targeted drug delivery using stimuli responsive platforms
Among various clinical options, chemotherapy tends to show a greater treatment
efficiency for the multiple diseases such as cancer, infections, inflammation and parasite. Critical
limitations that leads to failures of the therapy includes systemic toxicities associated with low
selectivity of cytotoxic drugs toward diseased tissues 15. Thus, targeted drug delivery arose as a
rational option to overcome those limiting factors via selective accumulation of therapeutic
agents at diseased tissues. Additionally, a combination of different therapeutic treatments is
necessary to improve the overall efficacy, including chemotherapy, photodynamic therapy,
surgery, and immunotherapy. The endeavor to incorporate multiple therapeutic agents in one
drug delivery system, for the combination cancer therapy tends to be achieved through complex
synthesis scheme with low yield and unpredictable pharmacokinetic profiles. Therefore, a drug
delivery system or drug with simple chemical construct, capable of differentiating tumor and
diseased tissue thus enabling targeted delivery of therapeutic agent is desirable. In this study, MB
based moiety with 10-N carbamoyl linkage was discovered and reported for its light and ROS
sensitivity. Subsequently, this moiety was applied in the syntheses of various stimuli-responsive
hybrid drug, molecular probes, theranostic agents, and self-assembly drug delivery materials.

4

CHAPTER II
METHYLENE BLUE AS A FAR-RED LIGHT-MEDIATED PHOTOCLEAVABLE
MULTIFUNCTIONAL LIGAND

2.1. Introduction
Methylene blue (MB), a synthetic phenothiazine fluorophore tolerable by the body, is an
attractive molecule possessing multiple properties useful for biomedical applications. In
particular, MB as a strong fluorescence dye shows an emission maximum at 680 nm which is in
the border between far-red and near infrared light. MB is also an effective therapeutic agent to
treat malaria, anaemia, Barrett’s oesophagus, and also as an antidote to methemoglobinemia. The
respective molecule is a potent photosensitizer that generates singlet oxygen (1O2) upon light
irradiation at 660 nm, a far-red wavelength,16–18 where its notable photo-cytotoxicity has been
prominently demonstrated against pathogenic bacteria19,20 and various cancer models17,18.
Interestingly, MB’s fluorescence (FL) becomes quenched upon chemical modification at its 10-N
site and becomes restored upon cleavage of the conjugated moiety due to the restoration of its
initial optical properties.
Photodynamic therapy (PDT) utilizing far-red to NIR light irradiation between 600-1000
nm has received much attention for its advantageous optical properties over UV-Vis-directed
PDT. Specifically, while UV-Vis PDT typically displays restricted applicability towards
externally exposed lesions due to its limited penetration depth, far-red PDT shows relatively
deeper tissue penetration depth with lower photototoxicity and thereby shows increased
therapeutic applicability.

21–23

However, there are very few known photoresponsive
5

chromophores capable of undergoing photochemical changes that directly absorbs the low
energy light in the far-red region 24,25. In light of this, considerable efforts in the past decade have
been invested into the development of far-red-activatable photosensitizers to facilitate the
clinical translation of PDT. Up to now, various MB-based off-to-on fluorescent imaging probes
have been reported where their fluorescence switch exploited the triggered deprotection of
chemically modified 10-N site on MB’s phenothiazine ring. Separately, responsive properties
were conferred to the probe by the conjugation of separate ligands that could undergo stimulisensitive activation (i.e. nitrobenzyl group by nitroreductase, and silyether by fluoride ion)
5,7,19

2–

.
In this study, we discovered a novel property of phenothiazine ring as a one-photon far-

red light-sensitive trigger moiety activatable at 660 nm (Scheme 1). A series of novel MBconjugates was synthesized as multifunctional compounds capable of intact MB release triggered
by far-red irradiation. In order to meaningfully test the validity of the proposed synthetic routes
and MB’s far-red sensitivity, Primaquine (PQ), an antimalarial agent used in the radical cure and
prevention of relapse from Plasmodium vivax and P. ovale parasites26,27, was chosen as a model
compound for MB conjugation. Ultimately, with precise manipulation of far-red irradiation using
a fiber optic device, spatio-temporal release of MB as an effective photosensitizer, imaging
probe, and therapeutic agent was successfully demonstrated. Herein, three carbamate bondcontaining derivatives of MB with varied 10-N residual groups, 4-nitrophenyl (MB-NP), pnitrobenzyl (MB-NB), and ethyl (MB-ET), were first synthesized by reacting leuco-methylene
blue with corresponding chloroformates as shown in Scheme 2, Schemes S1, and S2 (ESI†).
Next, four 10-N modified MB conjugates, MB-PQ, MB-EA-PQ, MB-EA and MB-EA-NP, were
synthesized by direct aminolysis of MB-NP.

6

Scheme 1. Proposed photolysis mechanism of urea bond-containing MB derivatives by far-red
light irradiation. Upon photon absorption, the molecule is excited to singlet state and
subsequently induce bond cleavage, yielding MB anion and R-carbocation. The transient
intermediates, stabilized by electron delocalization within the phenothiazine ring and electron
pushing effect of the residual R moiety, will be irreversibly hydrolysed and oxidized to yield
permanent cleavage of the urea bond. Resultant reduced form of MB could be oxidized by
dissolved oxygen and later 1O2. Scheme 1 was adopted and modified from photolysis mechanism
of (coumarin-4-yl) methyl ester.28,

Scheme 2. List of four urea bond-containing and three carbamate bond-containing MB
derivatives and their respective chemical structures
2.2. Results and discussion
The far-red light-triggered MB release from synthesized MB derivatives was evaluated
by measurements of the spectral changes upon exposure of test solutions to a controlled far-red
light. Initially, all MB-derivatives showed no absorption or fluorescence emission in the visible
and longer wavelength In contrast, all four urea bond-containing MB derivatives could release
7

MB upon exposure to far-red light as shown in Figure 1a-c and Figure S1a-f (ESI†), and
markedly enhanced the intensity of fluorescence emission as well as the characteristic absorption
bands originated from MB. This observation was further corroborated by the HPLC analysis of
far-red light-irradiated test solutions that showed a decrease in MB-EA-PQ peak intensity as well
as the appearance of MB peak at short retention time and gradual increase in peak intensity
(Figure 1d). Furthermore, released MB was quantitated and the accumulated results showed that
MB release from all MB derivatives virtually completed within 20 min of far-red light irradiation
(Figure 1c). Importantly, the cumulative photo-energy applied to the respective test solutions was
determined to be 15 J/cm2, which fell within the energy range of 18-36 J/cm2 that is commonly
used in clinical PDT.
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Such correlation indeed demonstrated the potential of our MB

derivatives for translation into biomedical applications.
The restoration of MB fluorescence from irradiated MB derivatives suggested that the 10N urea bond is readily susceptible to photolysis yielding leuco-MB, which is subsequently
oxidized into MB molecule (Scheme 1).15 As expected, the bond-cleavage site was confirmed by
the NMR spectral changes that showed a gradual disappearance of the -NH- proton peak
corresponding to the aforementioned urea bond (Figure 2a). However, the time required for a
complete disappearance of the peak was estimated to be around 60 min, which was significantly
longer than the time taken for fluorescence restoration (20 min). Such discrepancy in the time
required for photolysis could be attributed to the differences in solvent composition. While the
solvent used for the NMR analysis was 1% D2O in deuterated acetone, fluorescence restoration
experiments were performed in 5 mM phosphate buffer:acetone (50:50) mixture. Therefore, this
result suggested that the solvent polarity may be an important factor in the photolysis of the urea
bond-containing MB derivatives. It is worth noting that acetone was used to obtain homogeneous
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Figure 1. (a) Fluorescence spectra of MB-EA-PQ solution subjected to far-red light irradiation.
The insert shows the change in emissive fluorescence intensity at 685 nm over time representing
the rate of MB release. (b) Absorption spectra of MB-EA-PQ subjected to far-red light
irradiation. The inserted image shows gradual color change of a test solution over light
irradiation. (c) Comparison of MB release rate from different MB derivatives. Closed symbols
represent MB derivatives containing urea bond (MB-EA, MB-EA-NP, MB-EA-PQ, and MB-PQ)
while open symbols represent MB derivatives containing carbamate bond (MB-NP, MB-ET, and
MB-NB). (d) HPLC chromatograms of MB-EA-PQ with far-red light irradiation.
solutions of all tested MB derivatives, including three carbamate bond-containing compounds, as
they are practically insoluble in water. Indeed, the presence of water was found to be crucial for
the far-red light-mediated photolysis of MB derivatives (Scheme 1), as confirmed by the
unnoticeable MB release from the irradiated MB-EA-PQ solution in 100% acetone (Figure S4a,
ESI†). On the other hand, MB-EA-PQ samples prepared with varying water content, 5 to 100%,
successfully demonstrated their ability to release MB upon far-red light irradiation. Determined
by such results, human serum was also tested to demonstrate the capability of MB derivatives to
be photolyzed in physiologically-relevant conditions.
9

The photosensitivity of MB derivatives to far-red light was demonstrated to be dependent
on the type of chemical bond at 10-N of the phenothiazine ring which links MB to a side group.
The photolysis results demonstrated that the urea bond-based derivatives could undergo a
complete photolysis, while those with carbamate bond showed negligible photolysis (Figure 1c);
this suggested that urea bond has notable selectivity to far-red light irradiation. It was
hypothesized that the carbamate bond at 10-N of phenothiazine ring is more resistant to the
photolysis than the urea bond, on the basis of the observations made from two structurally
similar compounds, MB-EA and MB-ET (Figure 2b). In contrast to the urea bond-based MB-EA
which was rapidly cleaved with merely 10 min of far-red light irradiation, the carbamate bondbased MB-ET was photolyzed only by UV irradiation. Such UV light-mediated photolysis of
carbamate bond on the phenothiazine ring in MB could be further inhibited by the conjugation of
a strong electron-withdrawing nitro-aryl group, MB-NB and MB-NP (Figure 2c).
The results suggested that the transient ions of both MB- and [R-NH-CO]+ formed from
the urea bond-based MB derivatives could be effectively stabilized by the electron delocalization
throughout the phenothiazine ring as well as additional electron pushing effect of the side group
(Scheme 1). However, as the carbocation of carbamate bond-containing derivatives consists of
an oxygen atom, [R-O-CO]+, which is inherently more electronegative than the nitrogen atom in
[R-NH-CO]+ , along with the conjugates coupled to strong electron-withdrawing moieties, the
carbocation becomes markedly destabilized. This effect, in turn, substantially increases the rate
of recombination of the two ions which subsequently decreases the photolysis rate by the far-red
light irradiation (Scheme 1). The carbocation can be stabilized by environmental factors such as
the presence of negatively charged hydroxyl ions, rendering rapid photolysis in a basic solution
(Figure S4b). 19,20

10

It has been reported that the urea-bond containing MB derivatives can be rapidly cleaved
by HOCl – a reactive oxygen species.

11,12

Hence, it was justifiable to question if the 1O2

generated by MB impurity in test samples could act as the initiator and driven factor for the
observed photolysis process. However, this scenario was ruled out when ascorbic acid was added
to convert all free MB impurity into leuco-MB before light irradiation, thus to prevent immediate
1

O2 generation in the early phase of light irradiation (Figure S4c). In addition to the far-red light-

triggered MB release, the hybrid compound with conjugated PQ was able to demonstrate
simultaneous release of PQ. Upon light irradiation, HPLC chromatogram of the MB-EA-PQ
hybrid showed a gradual decrease in the intensity of the peak that corresponded to intact MBEA-PQ. Simultaneously, peaks corresponding to MB and PQ appeared in the earlier retention
time (Figure 1d and Figure S6). Additionally, LC-MS extracted ion chromatogram (EIC) of the
MB-EA-PQ after far-red light irradiation revealed three fragments at 373, 286 and 175 Da,
corresponding to EA-PQ, PQ and quinoline ring, respectively (Figure 2d). The 373 Da fragment
was suggested to be the product of the photolysis rather than the ionization process since the
MB-EA-PQ was fully photolyzed prior to the MS measurements. The complete photolysis was
also confirmed through the absence of 658 Da peak that corresponds to the molecular weight of
the hybrid compound (Figure S7c-f).
Even with fast growing fiber optic technology leading to the advancement of smaller tips
and better accessibility available for deep-tissue regions

3,21,22

, the skin still remains as the most

widely modelled tissue for the evaluation of phototherapy. Additionally, MB-based
photodynamic therapy has been extensively studied for the treatment of skin-related diseases
including bacterial infections and skin cancer.

18,23

HaCaT cell line, which is commonly used to

evaluate therapeutic molecules for skin diseases, was chosen for this study.
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Figure 2. (a) NMR spectra of MB-EA-PQ in 1% v/v D2O in deuterated acetone. (b)
Fluorescence intensity of MB-EA and MB-ET solutions stemming from freed MB after the
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Here, FL microscope imaging and cell 1O2 mediated photo-cytotoxicity measurement
based on MTT assay were employed to examine MB-EA as a fluorescent switch activatable by
far-red light. Upon far-red light irradiation, MB was released from the MB-EA, which, in turn,
resulted in extensive intracellular fluorescence. The enhancement of intracellular fluorescence
intensity would be useful for imaging modality to trace activation of MB derivatives (Figure 3a).
As expected, untreated and EA-treated samples did not show any noticeable FL emission in the
intracellular region. 1O2 generation by MB released from MB-EA was tested by cell cytotoxicity
measurement using MTT assay and p-nitrosodimethylaniline bleaching. MB, proven as a potent
photosensitizer, showed greatest cellular phototoxicity among all tested solutions, resulting in
cell viability of 2.4 ± 0.08 % at 20 µM. MB-EA also demonstrated substantial phototoxicity
towards the treated cells, resulting in cell viabilities of 16.1 ± 16.7 % and 35.1 ± 31.5 % at 20
µM and 10 µM, respectively (Figure 3b and Figure S8). Furthermore, the cell viabilities in
MB+irradiation and MB-EA+irradiation groups were statistically lower than those of unirradiated counterparts (p<0.05, n=3) and EA-treated group (p<0.05, n=3). These results
suggested that the MB released from MB-EA was active for 1O2 generation, which subsequently
could induce cell death. The difference in cell viabilities between MB and MB-EA treated
groups could be attributed to the amount of 1O2 generated. Upon far-red light exposure for a
fixed period of time, the MB group indeed generated more 1O2 than the MB-EA group, as
indirectly compared by bleaching level of p-nitrosodimethylaniline (Figure S9). It was postulated
that the energy of the far-red light applied to the MB-EA group was consumed by two
simultaneous photochemical reactions – photolysis of MB-EA and 1O2 generation. In contrast,
only one photochemical reaction occurs in the MB group, the generation of 1O2, and thereby
generates more 1O2 than MB-EA upon receiving the same amount of photo-energy.
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Figure 3. (a) Fluorescence microscope images of HaCaT cells treated with 10 µM MB, MB-EA
and EA before and after far-red light irradiation for 20 min at 660 nm at a total irradiated
energy of 9.8 J/cm2. Phase contrast images were taken from same locations. (b) Cell viability
measured on cultured HaCaT cell upon far-red light irradiation after treated with MB
derivatives. Untreated and light-protected cells were used as controls (n=3).
2.3. Conclusion
In summary, the urea bond-containing MB derivatives were successfully synthesized to
demonstrate triggered MB release upon far-red light irradiation at 660 nm, suggesting them as a
novel photo-cleavable ligand. This MB-based ligand can offer various synthetic applications for
the development of molecular theranostic agents enabling traceable activation via “off-on”
fluorescence switching as well as phototherapy modality via singlet oxygen generation via MB
release. The application of this strategy can be further expanded by the covalent conjugation of
therapeutic drugs of which therapeutic effects can be synergistically enhanced with MB.
14

2.4. Materials and methods
2.4.1. Materials
Methylene blue (MB) hydrate 96+% and was obtained from Acros Organic (Pittsburgh,
PA). 4-Nitrophenyl chloroformate, carbonyl diimidazole, ethylchloroformate, triethylamine,
ethanolamine and sodium dithionite were purchased from Fisher Scientific (Hampton, NH).
Primaquine

diphosphate

was

purchased

from

Carbosynth

(Berkshire,

UK).

p-

nitrosodimethylaniline, thiazolyl blue tetrazolium Bromide (MTT reagent) were obtained from
Sigma-Aldrich (Saint Louis, MO). HACAT cells and optimized DMEM media were purchased
from Addexbio Technologies, CA, USA. Penicillin-Streptomycin (10,000 U/mL), Dimethyl
sulfoxide and Trypsin-EDTA was purchased from Fisher Scientific, MA, USA. All other
chemicals were purchased from Fisher Scientific (Pittsburgh, PA) and used as received.
2.4.2. Detailed description of the synthesis
Leuco-methylene blue (L-MB): Methylene blue monohydrate (1,200 mg, 3.2 mmol)
was dissolved in 100 ml of deionized water. Toluene (150 ml) was added to the solution of MB
followed by nitrogen flushing. After a constant nitrogen flow was established, sodium dithionate
(1,116 mg, 6.4 mmol), followed by sodium carbonate anhydrous (680 mg, 6.4 mmol) was added
to the reaction mixture while stirring at 50oC. After 15 min of vigorous stirring, the reaction
mixture turned into yellow and both phases became clear indicating that leuco-methylene blue
was successfully transferred into toluene phase.
MB-NP, MB-ET and MB-NB: Toluene phase containing L-MB was transferred into a
nitrogen-discharged flask containing anhydrous sodium sulfate for drying under a nitrogen
atmosphere via dropwise addition over 10 min. Resultant anhydrous L-MB solution in toluene
was transferred into a solution of each chloroformate solution dissolved in 10 ml of toluene
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Scheme 3. Synthetic scheme of carbamate bond-containing MB derivatives MB-NP, MB-NB and
MB-ET. Reagents and conditions: (1) MB, sodium dithionate, sodium carbonate, water/toluene,
50oC, 1 h; (2), (3) and (4): leuco methylene blue, 4-nitrophenyl chloroformate (2) or ethyl
chloroformate (3) or 4-nitrobenzyl chloroformate (4), triethylamine (TEA), dry toluene, 2-4oC
1h, room temperature (RT) 24 h. The synthesis of MB-NB has been previously described1.
maintained in an ice bath; 4-nitrophenyl chloroformate (1,286 mg, 6.4 mmol) for MB-NP, ethyl
chloroformate (646 mg, 6.4 mmol) for MB-ET and 4-nitrobenzyl chloroformate for MB-NB1.
Upon completion of transferring L-MB into each chloroformate solution, TEA (1,692 µl, 12.8
mmol) was added. The reaction was proceeded overnight at room temperature. Then, reaction
mixture was collected after rinsing three times with each of the following solutions using a
separatory funnel: saturated sodium bicarbonate, 0.01N hydrochloric acid solution, and brine.
The obtained organic phase was dried, evaporated under reduced pressure and recrystallized in
acetonitrile 2 times and yielded a bright orange solid crystal of MB-NP (450 mg, 31%), black
solid crystal of MB-ET (300 mg, 26%) or dark red crystal of MB-NB1.
MB-PQ and MB-EA: MB-NP (450 mg, 1.0 mmol) was dissolved in anhydrous THF and
added dropwise into PQ base (1030 mg, 2.0 mmol) or ethanolamine (620 mg, 11.11 mmol).
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Later TEA (259 µl, 2.0 mmol) in anhydrous THF solution was added to the solution. The
reaction mixture was protected from light during reaction and refluxed at 60oC for 24 hours.
Upon completion of the reaction, the mixture was collected, evaporated under reduce pressure,
dissolved in DCM and washed three times with each of the following solutions: saturated sodium
bicarbonate, and water. The obtained organic phase was dried, evaporated under reduced
pressure and subjected to flash column chromatography using hexane:ethylacetate 1:1, and later
100% acetone. The eluted solution was evaporated under reduced pressure to yield a light green
powder of MB-PQ (490 mg, 85%) or light blue powder of MB-EA (230 mg, 75%).
MB-EA-NP: 4-Nitrophenyl chloroformate (400 mg, 2.0 mmol) was dissolved in
anhydrous DCM and added dropwise into MB-EA (350 mg, 1.0 mmol) solution in 10 ml
anhydrous DCM in an ice bath. After reacting 30 min, the reaction was run at room temperature
for another 8 hr. The reaction mixture was collected after washing three times with each of the
following solutions: saturated sodium bicarbonate, and brine.

Scheme 4. Synthetic scheme of urea bond-containing MB derivatives. Reagents and conditions:
(1) MB-NP, primaquine (PQ) base, anhydrous tetrahydrofuran (THF), TEA, 60oC reflux 24 h.
(2) MB-NP, excess ethanolamine (EA), anhydrous THF, TEA, 60oC reflux overnight. (3) MB-EA,
4-nitrophenyl chloroformate, TEA, anhydrous dichloromethane (DCM), 0-4oC 1 h, RT 24 h. (4)
MB-EA-NP, PQ base, anhydrous DCM, TEA, RT 24 h.
17

The obtained organic phase was dried, evaporated under reduced pressure and subjected to flash
column chromatography using hexane:ethylacetate 2:1, and later 100% acetone. The eluted
solution was evaporated under reduced pressure to obtain a light brown powder (230 mg, 80%).
MB-EA-PQ: MB-EA-NP (200 mg, 0.372 mmol) was dissolved in 10 ml anhydrous
DCM and added dropwise into PQ base (115 mg, 0.446 mmol), TEA (186 mg, 1.86 mmol) in
DCM solution. The reaction mixture was protected from light during the reaction and kept at
room temperature for 24 hrs. The obtained organic phase was dried, evaporated under reduced
pressure and subjected to flash column chromatography using hexane:ethylacetate 1:1, and 100%
ethylacetate. The eluted product solution was evaporated under reduced pressure yielding a light
green powder of MB-EA-PQ (220 mg, 90%).
2.4.3. Procedures for light irradiation
A LumaCare® LC-122A equipped with 24W halogen lamp (non-coherent light source)
and a 660 nm optic fiber probe with 325 mW/cm2 light intensity at the fiber tip was used for all
far-red irradiation experiments. The light intensity at the irradiated samples surface was
estimated based on the distance from the fiber tip to the sample. Generally, sample placing 25.42
mm from the optic fiber tip will be subjected to a 25 mW/cm2 incident light intensity. An UltraLUM UV crosslinker chamber, model AEX-800 was used for all UV irradiation experiments.
The 6 x 6-watt mercury lamps mounted on the ceiling emit 365 nm wavelength light. The
intensity of light inside the chamber varied from 1.5 to 2.0 mW/cm2 during the operating time.
2.4.4. Measurements of fluorescence emission and absorbance
Fluorescence measurements were performed using a LC500 Perkin Elmer fluorescence
spectrophotometer at 660 nm excitation wavelength, 600 to 800 nm emission wavelength, 10 nm
excitation slit and 10 nm emission slit. MB derivatives were completely dissolved and diluted in
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a solvent mixture of acetone and 1 mM pH 7.4 phosphate buffer at a ratio of 50:50 unless
otherwise stated. The sample concentration was kept below 10 µM to warrant the linear
relationship between fluorescence intensity and MB concentration without MB aggregation.
Exactly 1 ml of the tested solution is loaded into a fluorescence cell and sealed with a paraffin
film to prevent solvent evaporation during the irradiation process. UV absorbance was scanned
using a Genesys 8 UV-VIS spectrophotometer. The sample concentrations were kept at around
50 µM since the detection sensitivity of UV absorbance is lower than that of fluorescence
emission.
2.4.5. High-performance liquid chromatography
High-performance liquid chromatography (HPLC) was performed using a Waters Breeze
system equipped with a UV detector at 265 nm, C18 100 x 4.6 5 µm column, at a flow rate of 1
ml/min. A mixture of acetonitrile and 0.1% triethylamine in water adjusted to pH 3.0 at a ratio of
70:30 was used as the mobile phase and injection volume was 10 µl. MB derivatives dissolved in
DMSO (100 µl) was spiked on top of 2 ml 0.01 M pH 7.4 phosphate buffered saline (PBS) or
simulated gastric fluid. Simulated gastric fluid was prepared so that the final solution contains
0.2 % w/v sodium chloride and 0.7% v/v hydrochloric acid, adjusted pH to be in 1.0-1.2.
2.4.6. Quantification of the amount of singlet oxygen generation
Singlet oxygen (1O2) generation from far-red light irradiated urea bond-containing MB
derivatives was monitored by oxidation and subsequently bleaching of p-nitrosodimethylaniline
(RNO). A solution mixture of MB-EA-PQ (50 µM) or MB (50 µM), RNO (200 µM) and
histidine (20 µM) was prepared in 10 mM pH 7.4 phosphate buffer:acetone 50:50. Test solutions
were irradiated with far-red light (660 nm, 24 mW/cm2).
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2.4.7. Mass Spectroscopy
LC-MS/MS analysis was conducted using a Waters Acquity BEH Shield RP18 column
(100 mm 2.1 mm i.d., 1.7 μm) on a Waters Acquity UPLC system (Waters, Milford, MA) that
consists of a binary solvent manager, sample manager, heat controlled column compartment,
photodiode array (PDA) detector, and Xevo G2-S QToF mass spectrometer. The instrument was
operated by MassLynx NT 4.1. The column and sample temperature were maintained at 40oC
and 10oC, respectively. The mobile phases were composed of 0.05 % formic acid of water (A)
and acetonitrile containing 0.05 % formic acid (B) using gradient elution at a flow rate of 0.3
mL/min as follows: 0-8 min, 5 % B to 95 % B; 8-10 min, 95 % to 100 % B. The analysis was
followed by a 3 min washing procedure with 100 % B and re-equilibration period of 3.5 min
with initial condition. A strong needle wash solution (90/10; acetonitrile/water, v/v) and weak
needle wash solution (10/90; acetonitrile/water) were used. The injection volume was 2 µL.
The MS experiments were carried out on a Xevo G2-S QToF mass spectrometer that was
connected to the UHPLC system via an ESI interface. The MS parameters was operated in the
positive ionization mode as follows: 0.8 kV capillary voltage; 15 V cone voltage; 85 and 450 °C
for ion source and desolvation temperature, respectively; 50 and 800 L/h for cone and
desolvation gas flows, respectively. Leucine-enkephalin was used for the lock mass at a
concentration of 2 ng/mL and flow rate of 5 μL/min. Ions [M+H]+ (m/z 556.2771 Da) and a
fragment ion (m/z 278.1141 Da) of leucine-enkephalin were employed to ensure mass accuracy
during the MS analysis. The lock spray interval was set at 30 s, and the data was averaged over
three scans. The mass spectrometer was programmed two steps between low (10 eV) and
elevated (15-40 eV) collision energies on the gas cell, used a scan time of 0.1 s per function over
a mass range of m/z 100–1500 Da.
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2.4.8. Cell study
The HACAT cells were cultured and maintained at 37 °C in a humidiﬁed atmosphere of
5% CO2 and 90% relative humidity. The optimized DMEM supplemented with 10% fetal bovine
serum, penicillin (100 mg/mL) and streptomycin (100 mg/mL) were used for cell growth. The
medium was replaced every other day in flask and when the cells reached 80-90% confluence,
cells were detached using Trypsin-EDTA. The detached cells were plated at a density of 20,000
cells/well in 48-well culture plates. On attaining cell confluence of 90–95%, media were
aspirated from plates. Three 48-well culture plates were treated with different concentration (20
and 10 µM) of MB, MB-EA and dissolved in serum free media. After incubation for 24 h, 2
plates were exposed to far-red light. One of the two irradiated plate was used for fluorescence
microscopic examination and the other plate was incubated for another 24 h. Third plate was
incubated for 48 h after MB, MB-EA and EA treatment. The cell viability in second and third
plate was estimated using MTT assay. The HaCaT cell viability in plates were estimated using
Thiazolyl Blue Tetrazolium Bromide (MTT) reagent. After the incubation of second and third
cultured plates, the media was aspirated and replaced with fresh serum-free media containing 0.5
mg of MTT reagent. These MTT reagent treated plates were incubated for 4 h at 37 °C in a
humidiﬁed atmosphere of 5% CO2 and 90% relative humidity. After incubation of cell culture
plates, the media was aspirated. Formazan crystals formed by live cells were dissolved in
DMSO. Synergy H1, microplate reader was used to record the absorbance in 48-well culture
plates. The absorbance of formazanin DMSO solution was recorded at 570 nm. The absorbance
at wavelength of 630 nm (contributed by excess of cell debris) was recorded and subtracted with
absorbance recorded at 570 nm. The percentage cell viability was calculated by comparing the
absorbance recorded from untreated cells as the negative control.
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2.5. Supporting figures and tables
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Figure S1. (a) to (c): Fluorescence spectra and (d) to (e) absorption spectra of MB-EA (4.825
µM), MB-EA-NP (4.825 µM) and MB-PQ (4.825 µM) solutions, respectively in acetone:10 mM
pH 7.4 phosphate buffer 70:30. Samples were irradiated with far-red light (660 nm, 8.21
mW/cm2, 5.08 cm from fiber optic tip, 1 cm2 irradiated area). The inserts show the change in
emissive fluorescence intensity at 685 nm over time representing the rate of MB release. The red
line represents fluorescence or absorption spectra of freshly prepared sample. All scans were
done in triplicate and average values were plotted. (g) to (i): Absorption spectra of carbamate
bond-containing MB derivatives MB-NP, MB-NB and MB-ET (30 µM) after far-red light
irradiation (660 nm, 8.21 mW/cm2, 5.08 cm from fiber optic tip, 1 cm2 irradiated area).
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Figure S8. Phase contrast microscope images of HaCaT cells treated with (a) 0.01 M pH 7.4
PBS buffer, (b) MB, (c) MB-EA and (d) EA after far-red light irradiation for 20 min at 660 nm
and at a total irradiated energy of 9.8 J/cm2. The pictures show the overwhelming presence of
round-shape cells in MB (positive reference) and MB-EA treated groups and demonstrate the
phototoxicity of MB and MB-EA. On the contrary, the pictures show little presence of the roundshape cells in PBS buffer and EA treated groups.
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Figure S9. Singlet oxygen generation from (a) 50 µM MB solution, (b) 50 µM MB-EA solution
and (c) solution without MB and MB-EA was monitored using p-nitrosodimethyleaniline upon
far-red light irradiation at a wavelength of 660 nm. Various irradiation times ranging from 0 to
40 min were used to determine the effect of irradiation time on singlet oxygen production. The
results show that both MB and MB-EA solutions were able to generate singlet oxygen.
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CHAPTER III
INSIGHT INTO HYDROXYL RADICAL-MEDIATED CLEAVAGE OF CAGEDMETHYLENE BLUE: THE ROLE OF FENTON’S CATALYST FOR ANTIMALARIAL
HYBRID DRUG ACTIVATION

3.1. Introduction
Reactive oxygen species (ROS), including superoxide anion, hydroxyl radical (˙OH),
hydrogen peroxide (H2O2), hypochlorous acid (HOCl), and singlet oxygen are transient oxygen
intermediates, which function as important signaling messengers under normal physiological
conditions. However oxidative stress, where the ROS levels is altered, has been linked to the
progression of several pathological conditions including cancers, autoimmune disorders,
inflammations, and parasite infections.

29,30

Studies on H2O2, the most stable ROS, have

estimated the extracellular concentrations of healthy cells to be in the range of 0.5-7 µM. In
contrast, under pathological conditions, it may be up to 100-fold higher with measurements as
high as 1.0 mM.

14,31

In light of redox homeostasis, exploiting elevated ROS levels for stimuli-

sensitive activation is a trending paradigm in designing drug delivery systems and theranostic
agents.
Methylene blue (MB), a synthetic phenothiazine fluorophore tolerable by the body, is an
attractive molecule possessing multiple properties useful for biomedical applications. In
particular, MB is a strong fluorescent dye, is currently revisited as
combined therapy with artesunate, and a potent photosensitizer

16,18,32

antimalarial agent in

where its notable photo-

cytotoxicity has been prominently demonstrated against pathogenic bacteria

27

19,20

and various

cancer models

18,32

. Interestingly, MB’s fluorescence (FL) becomes latent upon the chemical

modifications at its 10-N site and is restored upon cleavage of the conjugated moiety due to the
reversal of fluorescence property. Various MB-based off-to-on probes have been reported to
exploit the triggered uncaging at 10-N site on the phenothiazine ring of caged MB derivatives.
Separately, the response to different triggers was conferred to the probes by the conjugation of
separate ligands that could undergo stimuli-sensitive activation (i.e. nitrobenzyl group by
nitroreductase, and silyether by fluoride ion) 2–5,7,19.
To further harness the off-to-on switch property of the phenothiazine ring, recently, a
series of caged MB derivatives via 10-N carbamoyl linkage were synthesized as the HOClsensitive probes and reported to have exclusive sensitivity towards HOCl, while described to be
relatively inert toward ˙OH and other ROS

5–11

. In this study, we thoroughly re-examined the

concept and reported that the 10-N carbamoyl MB derivatives were also sensitive to ˙OH to a
similar extent as HOCl (
Scheme 5). Our new findings, based on comprehensive understanding of Fenton’s system, were
primarily attributed to the effectiveness and efficiency of the protocol utilized to generate ˙OH.
The current paradigm utilizing inorganic Fe2+ ion species in excess molar equivalent to H2O2 to
trigger the Fenton reaction at physiologically relevant pH was reported to be extremely
inefficient as compared to the use of hemoproteins. To meaningfully and reliably verify the ˙OH
sensitivity of caged MB derivatives, malaria-infected erythrocytes (ETCs), known to have
elevated ROS levels, were chosen as the in vitro model and two primaquine (PQ) conjugated MB
derivatives were synthesized 27,33.
Herein, three carbamate bond-containing and four urea bond-containing derivatives of
MB with varied 10-N residual groups were synthesized (Scheme 1b). The detail synthetic route

28

have been previously described in our published study.12

Scheme 5. (a) Hydroxyl radical triggered MB-releasing platform and the Fenton reaction using
different catalysts at physiologically relevant pH. (b) The list of urea bond-containing and
carbamate bond-containing MB derivatives, and their respective chemical structures.
Fe2+ + H2O2 -> Fe3+ + ˙OH + OHFe3+ + H2O2 -> Fe2+ + ˙OOH + H+

(eq. 1)
(eq. 2)

Chemical equations for the Fenton Reaction34,35, .
3.2. Results and discussion
The ˙OH triggered MB release from synthesized MB derivatives was evaluated by
measurements of the spectral changes upon exposure of test solutions to ˙OH. Initially, MB-EA
and other derivatives showed no FL emission in the longer wavelength region. In contrast, all
urea bond-containing MB derivatives could release MB upon exposure to ˙OH as shown in
Figure 1a-b and Figure S1, and markedly enhanced the intensity of the MB characteristic FL
spectra. The ˙OH sensitivity of caged MB derivatives was demonstrated to be dependent on the
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type of chemical bond at 10-N of the phenothiazine ring which links MB to a side group. Figure
1b demonstrated that the urea bond-based derivatives could undergo a complete uncaging,
manifested through the FL restoration, while those with carbamate bond showed negligible
cleavage. The hypothesis was further corroborated by the HPLC analysis of two structurally
similar compounds, MB-EA and MB-ET, upon exposure to ˙OH (Figure 1c). In contrast to MBEA which was rapidly cleaved within 5 min by ˙OH, the carbamate-bond-containing MB-ET was
practically intact.
Although the concept of MB sensitivity towards ˙OH was successfully demonstrated
using the Fenton reagent in acidic environments, it is of paramount importance that this ligand
can function properly at physiologically relevant pH. Hence, MB-EA was prepared in solutions
with different pH values and the generation of ˙OH was subsequently triggered through the
addition of Fenton’s reagent, FeSO4.7H2O. Surprisingly, in contrast to initial expectations,
Figure 1d demonstrated lowering plateau values for MB release with increasing pH, and only a
negligible amount of MB-EA was cleaved at pH 7.4. Further investigations revealed that the use
of inorganic Fe2+ species and H2O2 as the combination for Fenton reaction could not effectively
generate ˙OH species, necessary for the cleavage of urea bond-containing MB derivatives
(Figure 1e-f).
The equally crucial factors that hinder the Fenton reaction at neutral pH were found to be
(1) the rate of oxidation of Fe2+ to Fe3+ by dissolved air oxygen (O2), and (2) the solubility of
both species. At pH close to neutral or alkaline, Fe2+ species participate in only the first reaction
(eq. 1); the resulting oxidized Fe3+ species is immediately precipitated due to extremely low
solubility, and hence could not be efficiently “recycled” into Fe2+. As a result, the amount of
˙OH and subsequently released MB exhibited an upper limit, possibly equal to the amount of
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Fe2+. In contrast, at lower pH, both iron species, Fe2+ and Fe3+, were effectively solubilized and
hence acted as a catalyst for the decomposition of H2O2, resulting in a substantially enhanced
conversion of H2O2 to ˙OH, and leading to complete MB-EA uncaging. Additionally, the rate of
Fe2+ oxidation increased exponentially with the increase in pH, which at pH 7.4 the total
conversion from Fe2+ to Fe3+ by dissolved O2 takes less than 5 min. 36 (Figure 1e and Figure S2).
This resulted in only a trace amount of Fe2+ species available to trigger the Fenton reaction.
Hence, the total amount of ˙OH decreased with the increase in time between preparation and the
initiation of the reaction. Additionally, the convergence of adjusted FL intensity profiles at
different pHs as a function of the incubation time approached zero suggested that the initial
amount of Fe2+ available for the generation of ˙OH was equal but rapidly decreased upon
exposure to the environments at designated pH (Figure 1e). Ultimately, even with all the
implemented precautions such as the use of lightly acidified stock FeSO4.7H2O solution,
nitrogen purging, and near-immediate measurement after the trigger of Fenton reaction; at pH
7.4 the use of 100:10:1 molar ratio of Fe2+:H2O2:MB-EA generated only a negligible amount of
˙OH (Figure 1f).
Collectively, this finding suggested that the relative inertness to ˙OH and resultant
HOCl-specific sensitivity reported to be associated with the MB-based probes5–11 and
possibly other HOCl selective probes (Table S1) were probably a conclusion based on false
negative results. The suggestion was proposed due to the use of similar 10-N carbamoyl MB
platform, and inorganic Fe2+ at pH 7.4 as the Fenton’s catalyst. Hence, future endeavours
to test the selectivity of new molecular probes towards ROS are suggested to take into
consideration the efficiency of the protocol to generate ˙OH.
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Figure 4. (a) FL spectra of MB-EA solution subjected to the treatment with ˙OH (Fenton
reagent, H2O2, FeSO4.7H2O, pH 4.0). (b) MB release from different caged MB derivatives.
Colored and black lines represent urea and carbamate bond containing MB derivatives,
respectively. (c) HPLC chromatograms of MB-EA and MB-ET upon the exposure to ˙OH. (d) MB
release profiles from MB-EA triggered by ˙OH at different pH values. (e) FL intensity of MB-EA
solution with varied incubation time with FeSO4 and subsequently triggered by the addition of
H2O2. (f) representative FL scan of pH 7.4 MB-EA solution with varied incubation time with
FeSO4 and hemoglobin.
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Therefore, it is postulated that hemoproteins, in which Fe(II) species was located inside
the prosthetic heme group, effectively solubilized by the protein’s hydrophilic chains, and was
relatively stable against oxidation by dissolved O2 will effectively generate ˙OH species at
neutral pH environments. Indeed, hemoproteins with peroxidase activity such as horseradish
peroxidase (Hp), hemoglobin (Hb), and cytochrome c (Cytc) were much more efficient Fenton
catalyst than Fe2+ ion at pH 6.0-8.5 leading to a total conversion of H2O2 to ˙OH, subsequently a
complete cleavage of MB-EA within time frame ranging from several seconds to a few minutes
(Figure 2a-b) 34. Intriguingly, although having four heme groups, the MB release profile utilizing
catalase for Fenton reaction was identical to FeSO4 Fe(II) species possibly attributed to its nonperoxidase activity in nature. The effectiveness of hemoproteins was also demonstrated by the
minimal amount of catalyst required for the sufficient generation of ˙OH, in which the molar
ratio of Hb:H2O2 as low as 1:100 was able to completely uncage MB-EA within 10 min (Figure
2c). Additionally, a linear relationship was observed with the amount of MB-EA and ˙OH, using
Hb as the representative catalyst (Figure 2d). Notably, even lower level of ˙OH (1 µM, 0.1 molar
ratio to MB-EA) induced a 10-fold increase in the FL intensity of MB-EA. In contrast, at a ˙OH
to MB-EA molar ratio higher than 1, ˙OH species may simultaneous participate in both
terminations of radical chain reactions and MB-EA uncaging thus resulting in a plateau in FL
intensity activation profile (Figure S3). Taken altogether, the results suggested that urea bond
containing caged MB derivatives could be used as a theranostic platform to target hemoproteins
possessing peroxidase activity in diseased tissues.
To facilitate the clinical translation of the platform as a ˙OH sensitive theranostic agent,
MB-EA, a urea bond containing caged MB derivative was investigated in vitro using ETCs as a
model of a hemoglobin-rich cell while treating H2O2 to simulate the elevated ROS condition.
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Figure 3a showed that Hb inside ETCs was capable of efficiently generating ˙OH upon the
treatment with H2O2, resulting in the cleavage of MB-EA and subsequent increase in intracellular
FL (Figure 3a-b). The enhancement of intracellular FL intensity would be useful for imaging
modality to trace the activation of MB derivatives, and to some extent quantify the concentration
of ˙OH. However, although the concept of ˙OH sensitive agent was illustrated, this experiment
was underscored by the fact that MB-EA was artificially and exogenously activated through the
addition of H2O2. It is therefore questionable whether the endogenously elevated ROS levels in
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Figure 5. FL restoration of MB-EA solution at pH 7.4 from freed MB after the treatment with
˙OH (a) utilizing different catalysts for the Fenton reaction, and (b) at different pHs. (c) MB
release profile upon treatment with ˙OH (H2O2 and varied Hb concentrations). The insert
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Figure 6. (a) FL microscopic images of ETCs treated with MB-EA (5 µM) and the combination
of MB-EA and H2O2. (b) FL intensity of respective wells (n=3).
Ultimately, the artificial factors involved in the induction of ROS were further minimized
to better simulate the pathological conditions. Malaria-parasitized ETCs, known to have
increased ROS levels compared to uninfected ETCs, were chosen as the model and subsequently,
MB derivatives were screened for the antimalarial activities. 37 Figure 4a showed that most urea
bond-containing MB derivatives (group II) have the IC50 values around30 nM, on par with the
physical mixture of MB:PQ at 1:1 molar ratio. This result suggested that the conjugates were
capable of being cleaved under the testing condition, possibly yielding MB and PQ separately
thus exerting antimalarial effect. MB-EA-NP is the only compound in group II that demonstrated
higher IC50 and lower selectivity index, possibly due to its chemically reactive nature that can
undergo aminolysis with naturally exist proteins and physiological compounds. Subsequently,
the cell membrane and physiological processes were disrupted. As a result, MB-EA-NP is
significantly more toxic towards VERO cells, compared to the other compounds in the same
group, as demonstrated by the lower IC50 (Table S2).
The desirable higher selectivity index of the group II compounds was presumably due to
the capability to be preferentially cleaved by elevated ROS levels inside the infected ETCs
cytosol, whereas remained relatively intact inside the uninfected ETCs or VERO cells.
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Figure 7. IC50 and selectivity index of MB, PQ, and its 1:1 mol. ratio physical mixture (group I),
urea bond containing MB derivatives (group II), and carbamate bond containing MB derivatives
(group III) against Plasmodium falciparum D6 and W2 malaria parasites. a Selectivity index is
the ratio between IC50 against VERO cells and parasitized ETCs. b Selectivity indexes of group
III could not be calculated due to the IC50 against VERO cells were out of tested range (>10 µM,
Table 1, ESI).
In contrast to the urea bond containing MB derivatives, compounds in group III were
relatively inert towards both infected ETCs and VERO, as demonstrated by significantly higher
IC50 in the range of two orders of magnitude, presumably because the carbamate bond at the 10N position of the phenothiazine ring is relatively stable. Beside the therapeutic effects, the
platform also demonstrated the capability to track the MB uncaging via FL restoration.
Interestingly, at tested concentrations in the micromolarity range, no difference in FL intensity
were observed between the parasitized and normal ETCs groups (Figure S4). This result was
possibly due to the rapid eradication of the malaria parasite at the concentrations significantly
higher than IC50. In contrast, as the concentrations approached the low nanomolarity range, FL
intensity in parasitized ETCs wells were significantly higher than that of normal ETCs
suggesting a higher level of ROS in the infected ETCs group (Figure 4b-c). Additionally, Figure
4b-c also showed that FL intensity of all samples at 48 h were higher than that of respective 24 h,
36
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Figure 8. FL intensity of MB-EA treated culturing wells that contained 4% parasitized and
normal ETCs. *At all tested concentrations, the FL difference was statistically significant (n=4).
and the significance between the two tested groups was maintained. This result suggested that
MB-EA was continuously being cleaved by elevated ROS in parasitized ETCs. It is noteworthy
to mention that in parasitized ETCs group, a mere 4% cells infected with malaria, resulted in a
130 to 250% increase in FL intensity compare to the normal ETCs group. Collectively with the
demonstrated exclusive sensitivity towards ˙OH and HOCl respectively reported in this study
and other researches5–7 it was rationally assumed that the increase in ROS concentration induced
the cleavage of urea bond containing MB derivatives. As a result, MB and the conjugated moiety
PQ were released, thereby exerting the antimalarial effect.

3.3. Conclusion
In summary, the urea bond-containing caged MB derivatives successfully demonstrated
the triggered MB release upon exposure to ˙OH. This 10-N carbamoyl MB ligand can offer
various synthetic applications for the development of theranostic prodrugs enabling both tracing
of oxidative stress in pathological tissues and subsequent activation of therapeutic drug
molecule. The application of this strategy can be further expanded by the researches on various
pathological models to target other hemoproteins.
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3.4. Materials and methods
3.4.1. Materials
Methylene blue (MB) hydrate 96+% and was obtained from Acros Organic
(Pittsburgh, PA). 4-Nitrophenyl chloroformate, carbonyl diimidazole, ethylchloroformate,
triethylamine, ethanolamine and sodium dithionite were purchased from Fisher Scientific
(Hampton, NH). Primaquine diphosphate was purchased from Carbosynth (Berkshire,
UK). p-nitrosodimethylaniline was obtained from Sigma-Aldrich (Saint Louis, MO).
Rabbit erythrocytes cells were purchased from Innovative Reseach, MI, USA. All other
chemicals were purchased from Fisher Scientific (Pittsburgh, PA) and used as received.
3.4.2. Detailed description of the synthesis
Detailed description of the synthesis, 1H NMR, FTIR and LC MS/MS characterizations
were previously published by our research group. Interested readers are referred to the following
study by Huy M. Dao, et. al., Methylene blue as a far-red light-mediated photocleavable
multifunctional ligand, Chem. Commun., 2020,56, 1673-1676
3.4.3. Preparation of solutions of MB derivatives and analytes
Stock solution of MB derivative (1 mM) were prepared in 1% acetonitrile in water. The
test solutions of MB derivatives (5 µM) in 10 mM PBS solutions pH 5.0 to 8.0 were prepared by
diluting 10 µl of stock solutions with corresponding PBS buffers. The time-drive experiments
were carried-out by placing 10 µl stock ferrous-ions containing solutions (FeSO4.7H2O or
hemoproteins) into caged MB derivatives test solution (5 µM) to achieve desired molar ratio.
Subsequently, the solution was incubated for 0 to 100 min. Upon the addition of H2O2 to trigger
the Fenton reaction, the intensity of fluorescence emission at 690 was recorded. As the
precautions to prevent Fe2+ to Fe3+ oxidation, all FeSO4.7H2O stock solutions were lightly
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acidified and purged with nitrogen for 5 min. The fluorescence intensity of the solutions at
different pHs were normalized using standard MB solutions at the respective pH. The conversion
from fluorescence intensity to percentage of MB release was calculated based on the assumption
that MB derivatives (5 µM) were completely cleaved to release 100% MB moieties when
incubated with H2O2 (50 µM) and horseradish peroxidase (5 µM) for 5 min.
3.4.4. Measurements of fluorescence emission and absorbance
Fluorescence measurements were performed using a LC500 Perkin Elmer fluorescence
spectrophotometer at 660 nm excitation wavelength, 600 to 800 nm emission wavelength, 10 nm
excitation slit and 10 nm emission slit. MB derivatives were completely dissolved and diluted in
a solvent mixture of acetone and 10 mM pH 5.0-8.0 PBS at a ratio of 5:95 unless otherwise
stated. The sample concentration was kept below 10 µM to warrant the linear relationship
between fluorescence intensity and MB concentration without MB aggregation. Exactly 1 ml of
the tested solution is loaded into a fluorescence cell and sealed with a paraffin film to prevent
solvent evaporation during the irradiation process.
UV absorbance was scanned using a Genesys 8 UV-VIS spectrophotometer. The sample
concentrations were kept at around 50 µM since the detection sensitivity of UV absorbance is
lower than that of fluorescence emission.
3.4.5. High-performance liquid chromatography
High-performance liquid chromatography (HPLC) was performed using a Waters Breeze
system equipped with a UV detector at 265 nm, C18 100 x 4.6 5 µm column, at a flow rate of 1
ml/min. A mixture of acetonitrile and 0.1% triethylamine in water adjusted to pH 3.0 at a ratio of
70:30 was used as the mobile phase and injection volume was 10 µl.
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3.4.6. Erythrocytes treated hydrogen peroxide study
Rabbit erythrocytes (ETCs) was obtained and use within 14 days due to its perishable
nature. The stock ETCs was diluted 10 times and treated with different concentration (2 to 20
µM) of MB-EA. After incubation for 4 hrs, the ETCs suspensions were centrifuged and the
supernatant was discarded. The ETCs were resuspended in 0.01 M pH 7.4 PBS solution.
Subsequently, the ETCs were treated with 50 µM H2O2 to simulate elevated ROS concentration
in disease model. Synergy H1 (Biotek, USA), microplate reader was used to record the
absorbance in 48-well culture plates. Fluorescent microscopy (Olympus, TX, USA) equipped
with a Texas red filter was utilized to capture the fluorescent microscopic image. All images are
taken at the same exposure time of 1.4 s to enable the comparison of fluorescence intensity of
different samples.
3.4.7. Assay for screening antimalarial activity and cytotoxicity
The antimalarial activity is determined against chloroquine sensitive (D6) and
chloroquine resistant (W2) strains of P. falciparum by measuring plasmodial LDH activity
according to the procedure of Makler and Hinrichs. The assay is performed in 96-well tissue
culture-treated plates. A suspension of red blood cells infected with D6 or W2 strain of P.
falciparum (200 µL, with 2% parasitemia and 2% hematocrit in RPMI 1640 medium
supplemented with 10% human serum and 60 µg/mL Amikacin) is added to the wells of a 96well plate containing 10 µL of serially diluted samples (plant extracts, column fractions or pure
compounds).
The plate is incubated at 37 O C, for 72 h in a modular incubation chamber with 90% N2 ,
5% O2 , and 5% CO2 . Parasitic LDH activity is determined by mixing 20 µL of the incubation
mixture with 100 µL of the Malstat reagent and incubating at room temperature for 30 min.
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Twenty microliters of a 1:1 mixture of NBT/PES (Sigma, St. Louis, MO) is then added and the
plate is further incubated in the dark for 1 h. The reaction is then stopped by adding 100 µL of a
5% acetic acid solution and the absorbance is read at 650 nm. Artemisinin and chloroquine are
included as the drug controls. IC50 values are obtained from the dose response curves of growth
inhibition.
The in vitro cytotoxicity of samples to mammalian cells is also determined in order to
calculate the selectivity index of the antimalarial activity. Vero cells (monkey kidney fibroblasts)
are seeded to the wells of 96-well plate at a density of 25,000 cells/well and incubated for 24 h.
Upon confluency, test samples at different concentrations are added and cells are further
incubated for 48 h. Cell viability is determined using a tetrazolium dye (WST-8). IC50 values are
obtained from dose response curves. Doxorubicin is included as drug control for cytotoxicity.
3.4.8. Measurement of FL intensity induced by elevated ROS levels in parasitized
erythrocytes
To evaluate the uncaging of MB-EA and resultant FL stemmed from the freed MB, P.
falciparum infected ETCs (4% parasitemia) and normal ETCs were incubated with presence of
increasing concentration of MB-EA (0.97, 2.93, 8.81, 26.44, 79.33, and 238 ng/ml) for 24 and 48
h at 37oC. After the incubation, plate was centrifuged at 2000 g for 5 min and supernatant was
transferred to a new clear bottom 96 well plate. FL intensity of the supernatant was measured at
660 excitation wavelength and 690 emission wavelength using Spectramax-M5 plate reader
(Molecular Decives, Sunnyvale, CA).
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3.5. Supporting figures and tables
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Figure S10. Absorbance spectra of MB-EA solution subjected to the treatment with ˙OH species
Fenton reagent, H2O2, (a) horseradish peroxidase, and (b) hemoglobin, at pH 7.4. (c) The profile
of MB release from MB-EA upon the incubation with H2O2.
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Figure S11. Fluorescence scan of MB-EA solutions incubated with FeSO4.7H2O at different pH
values, for an increasing amount of time.
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Figure S13. FL intensity of MB-EA treated culturing wells that contained 2% parasitized and
normal ETCs. (n=4). No statistically significance was observed between the groups.
Table 2. Half maximal inhibitory concentration (IC50) of MB, PQ, physical mixture, urea bond
containing and carbamate bond containing MB derivatives against Plasmodium falciparum D6
and W2, and VERO cells.
IC 50 (nM)
MB
PQ
MB+PQ
MB-EA
MB-EA-NP
MB-EA-PQ
MB-PQ
MB-NP
MB-NB
MB-ET

P. f D6
13.1
4324.5
26.8
26.8
46.1
32.1
31.9
9257.3
1219.9
3785.8
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P. f W2
12.8
1882.8
42.1
25.2
53.4
29.2
35.4
9516.3
1351.7
1736.4

VERO
1531.3
>10453.7
1176
9823.1
2722.1
5995.5
8339.8
>10565.8
>10246.7
>13315.8

Table 3. List of HOCl probes and associated protocol to generate hydroxyl radical (˙OH).
DOI and reference

˙OH generation protocol

Chemical
platform

1

10.1039/c7sc03784h

Methylene blue
(Phenothiazine)

2

10.1002/anie.201813648

Methylene blue

3

10.1039/c8ra01037d

Methylene blue

4

10.1016/j.dyepig.2020.10
8308

Methylene blue

5

10.1016/j.dyepig.2020.10

Phenoxazine

pH 7.4 PBS
FeSO4

6

10.1021/acs.iecr.7b00381

Fluorescein

7

10.1021/jacs.5b01881

Tetrafluoro
fluorescein

8

10.1039/c8cc03963a

Thiocarbamate
Naphthalene

9

10.1039/c5sc03855c

Fluorescein

10

10.1002/anie.201500537

-nitro-benzo
[1,2,5] oxadiazole

11

10.1039/c3cc44463e

BODIPY – Ox

12

10.1021/ja505988g

BODIPY

13

10.1039/c3cc47864e

Selenomorpholine

14

10.1039/c4cc07411d

Phenothiazine ring

15

10.1039/c4cc02673j

Benzoyl
acetohydrazide

16

10.1021/acs.analchem.6b
01738
10.1039/C8AN00586A

pH 7.4 10 mM PBS
Fe2+ : H2O2 : probe (10 : 10 : 1 mol. equiv. )
Type of ferrous salt not specified
pH 7.4 10 mM PBS
FeCl2 : H2O2 : probe (1000 : 10 : 1 mol. equiv.)*
[˙OH] assumed equal to [Fe(II)]
pH 7.4 10 mM PBS
FeCl2 : H2O2 : probe (1000 : 10 : 1 mol. equiv.)a
[˙OH] assumed equal to [Fe(II)]
a
Follows protocol from #5
pH 7.4 0.1 M PBS
FeCl2 : H2O2 : probe ( 10 : 1 :1 mol. equiv.)
[˙OH] assumed equal to [Fe(II)]
pH 7.4 10 mM PBS
Fe2+ : H2O2 : probe ( 500 : 100 : 1 mol. equiv.)
[˙OH] is assumed to be equal to [H2O2]b
b
Follows protocol from Chang’s Group38
pH 7.2 buffer
FeCl2 : H2O2 : probe ( 20 : 200 : 5 mol. equiv.)
pH 7.4 buffer
X : H2O2 : probe ( X : 10 : 1 mol. equiv. )
No information about iron species found
pH 7.4 20 mM PBS
No information found
pH 7.3 10 mM PBS
100 : 1 (OH : probe)
pH 7.4 20 mM PBS
Fe(ClO)4 : H2O2 : probe (100 : 200 : 1 µM)
pH 7.4 50 mM PBS
FeCl2 : H2O2 : probe (200 : 400 : 2 µM)
*OH was freshly prepared
*OH : probe (100 : 1)
No information found

17

Porphyrin

pH 7.2 10 mM PBS
FeCl2 : H2O2 : probe (100 : 10 : 1 mol. equiv.)
[˙OH] assumed equal to [H2O2]
pH 7.2 10 mM PBS
FeSO4 : H2O2 : probe (40: 4 : 1 mol. equiv.)
[˙OH] assumed equal to [H2O2]
pH 7.4 10 mM PBS
˙OH generation protocol not described
Not described
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CHAPTER IV
REACTIVE OXYGEN SPECIES AND LIGHT DUAL-SENSITIVE LIPOSOME FORMING
MATERIAL
4.1. Introduction
Recently, methylene blue (MB) moiety with a 10-N carbamoyl linkage has been reported
to be a dual ligand responsive to both light and ROS, capable of being cleaved from the parent
compound upon exposure to such stimuli. The potential biomedical applications of MB ligand
has been successfully demonstrated through the syntheses of various ROS sensitive compounds
including HOCl molecular probes11,39–41, ˙OH sensitive hybrid drugs42. Separately, the
application of MB moiety was also examined for the synthesis of far-red light mediated hybrid
drugs, theranostic agent12, and novel materials for drug delivery purposes43. Hence, a
combinative study that utilize both light and ROS for the trigger of MB based compound is
desirable to explore the versatility of the novel moiety. Additionally, gained knowledge will
provide a more comprehensive view of the applicability of MB in clinical settings including
molecular probes, hybrid therapeutic agents, and drug delivery materials.
MB is proposed to be utilized as the cleavable moiety for the dual light and ROS
mediated degradable material. The cleavage of MB from the parent materials, is presumed to
result in the changes in physicochemical properties such as the balance between hydrophobicity
and hydrophilicity, due to the exposure of the functional group that previously linked to MB and
the leaving of the phenothiazine ring. Subsequently, these changes are assumed to result in
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self-assembled properties of the materials and their associated drug delivery systems. As a result,
disruption of the assemblies will be translated into the release of therapeutically-active payload.
Furthermore, the released MB molecule, can be harvested for diagnostic and therapeutic
purposes. (1) Specifically, the released MB, as opposed to LMB, will possess strong
fluorescence properties that can be utilized to roughly estimate the extent of the ROS inside the
diseased tissues. Additionally, the fluorescence signal can also be used to track the activation of
the drug delivery systems. (2) More importantly, in subsequent to the release of MB by ROS, the
released MB can be utilized to applied photodynamic therapy to the diseased tissue through the
application of a 660 nm wavelength red-light irradiation.
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), is a synthetic phospholipid,
known to form hexagonal cubic phase and associated inverse micelle. This assembly tendency is
attributed to its inverted conical molecular shape with small hydrophilic head group composes of
phosphate and ethanolamine (Scheme 6). However, upon the acetylation of the primary amine,
the head group size was increased yielding a different self-assembly structure. In light of this,
acetylated DOPE such as 6-nitroveratryloxycarbonyl chloride (NVOC)44 and trimethyl quinone45
DOPE have been synthesized and demonstrated to have higher critical packing parameter (CPP0
than original DOPE molecule. Subsequently, NVOC and quinone DOPE adopt lamellar
assembly structure and exhibit liposome forming tendency. Upon the treatment with UV 300 nm
and reducing agent, NVOC and quinone were respectively cleaved from the parent compound
thus restoring the original CPP. As a result, the lamellar structure was disrupted, leading to the
disruption of liposome vesicle and the release of payload. In this study, DOPE was utilized as the
base material to be conjugated with MB moiety that is sensitive to far-red light and ROS, to form
a dual-sensitive liposome forming material (Scheme 6).
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Scheme 6. Molecular shape and associated self-assembled structures of MB-DOPE and DOPE,
upon exposure to hydroxyl radicals and light.
4.2. Results and discussion
MB-DOPE was successfully synthesized through the aminolysis of primary amine and
MB-EA-NP (Scheme 7). Liposome of MB-DOPE was prepared in pH 7.4 0.01 M phosphate
buffer using the technique of hydrated lipid film extrusion. Indeed, MB-DOPE was demonstrated
to possess the ability to form lipid bilayer and subsequently liposome. Representative images
from TEM experiments showed a core-shell like structure indicating the formation of a lipid
bilayer (Figure 9a). Dynamic light scattering (DLS) experiments revealed that the liposomes
were homogenous with diameters range from 80-200 nm (Figure 9b). Additionally, the gel-liquid
crystal transition temperature (Tm) of MB-DOPE was suggested to be between 50-60oC. Results
from Figure 9b insert showed that as the temperature increase from 20 to 40oC there is no change
in liposome average size and size distribution, suggesting the liposome is relatively intact.
However, as the temperature was increased above 50oC, the size getting bigger, suggesting the
softening of the lipid bilayer, and hence promoting the fusion of liposome into bigger vesicles.
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Figure 9. (a) Representative transmission electron microscopy (TEM) image of MB-DOPE
liposomes. (b) Size distribution of liposomes dependent on temperature.
The UV light-triggered MB release from MB-DOPE liposome was evaluated by
fluorescence intensity measurement upon exposure of test solutions to a controlled UV 365 nm
light. Initially the liposome suspension showed no fluorescence emission in the visible and
longer wavelength. In contrast, the MB-DOPE liposome could release MB upon exposure to UV
as shown in Figure 10a, and markedly enhanced the intensity of MB’s characteristic fluorescence
emission at 685 nm. Interestingly, the fluorescence emission spectra of MB-DOPE suspension at
the early stage showed a notable peak at 660 nm in contrast to the relatively flat spectra of
soluble MB derivatives (Figure 1a, S1a-c). The presence of a peak further corroborated the
existence of a nanoparticle population possibly corresponding to liposomes. The 660 nm
excitation light was thought to be scattered by the nanoparticles resulting in a signal recorded by
the detector. Eventually, this 660 nm peak was overshadowed by the 685 nm emission peak as
the result of the released MB.
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Figure 10. (a) Fluorescence intensity, (b) average size and PDI, and (c) size distribution of MBDOPE liposomes suspension upon irradiation with 365 nm UV light.
The UV light-triggered cleavage of MB yielding original DOPE was translated into
change into critical packing parameter, exerted structural stress, and ultimately led to liposome
disruption. Specifically, upon irradiation by UV light for 20 min, the size distribution of
liposome population dramatically shifted to the micrometer range (Figure 10b-c). This change
was also accompanied by a considerable increase in polydispersity index (PDI) from 0.15 to
almost the maximum value of 1.0, visually reflected by the multimodal size distribution after 20
min UV irradiation. The cleavage of MB from MB-DOPE was suggested to result in a change in
geometrical shape from cylindrical to conical. Subsequently the critical packing parameter and
the ability to self-assemble into lamellar phase is lost. This exerted a structural stress on the
liposome, but liposome still capable of maintaining the overall shape up to a certain degree of
MB cleavage (Scheme 6). The representative TEM image of the supernatant of UV treated
sample demonstrated the absence of the liposomal structures across the field of view.
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Hydroxyl radical has been previously demonstrated to be the stimuli that trigger the
uncaging of MB from urea bond containing MB derivatives
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. Since MB was conjugated to

DOPE via a urea bond, it was initially expected that the MB-DOPE liposome will be sensitive to
˙OH. Indeed, data from Figure 11a was in accordance with the assumption as after 10 min of
treatment of ˙OH the MB characteristic FL peak increased dramatically. There is no difference
after the incubation for 1 day, suggesting the MB cleavage is completed within 10 min.
Interestingly, after the treatment when MB has been completely uncaged, the size distribution of
the liposomal nanoparticle only shifted to a slightly bigger population. After further incubation at
room temperature for 24 h, the nanoparticle population almost completely disappeared, while
peak at the micron range emerged. This results suggested the existence of transient unstable
nanostructures, that was under structural stress induced by the change in geometrical shape of the
constituent DOPE. The transient structures gradually yield to the stress to form inverse micelles,
and eventually aggregated into clumps of naked eye visible chunk of floating aggregates. It is
worthy to note that the inherent upper limit of the Zetasizer is about 5-6 µm, hence the size
distribution suddenly dropped down at the value of 5, despite the particles can be bigger. The
whole sample, as opposed to just supernatant in the case of UV sample, was taken for TEM
microscopic visualization. Representative TEM images (Figure 11c-d) demonstrated the absence
of liposomal structure and the presence of large aggregates supposedly composing of inverse
DOPE micelles. In order to meanfingfully test if the ˙OH-induced change in particle size could
be translated into release of payload, calcein loaded MB-DOPE liposome was prepared and
subjected to treatment with ˙OH. Figure 11e, the calcein leakage experiment, showed that MB
cleavage indeed leads to liposome disruption, indirectly manifested by the increase in calcein
emission characteristic FL peak at 515 nm upon excitation by 495 nm light.
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Figure 11. (a) FL emission spectra and (b) size distribution of blank MB-DOPE liposomes upon
treatment with ˙OH. Representative TEM images of MB-DOPE liposomes (c) before, and (d)
after treatment with ˙OH. (e) FL emission spectra of calcein loaded MB-DOPE liposome
4.3. Conclusion and future remarks
In summary, a novel liposome forming material MB-DOPE has been successfully
synthesized. The light-sensitive and reactive oxygen sensitive properties associated with the urea
bond containing MB derivatives have been applied and translated into a dual-stimuli sensitive
material. The MB-DOPE liposomes have been demonstrated to undergo structural disruption and
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subsequently release the payload. This drug delivery platform can offer multiple benefits for the
treatment of various diseases which include (1) passive targeting to disease tissues with elevated
ROS level, (2) active temporal control release of payload through light irradiation, (3) enhanced
FL imaging to track the distribution of carriers, (4) released MB can be further exploited as
auxiliary photodynamic therapy. Although being promising, further study should be carried-out
to address the inherent issues related to the MB based material platform, such as (1) proving its
effectiveness as ROS-mediated targeting capability through disease models, and (2) fine tuning
the physicochemical characteristic of the MB moiety to achieve better imaging capability and
lower hydrolysis rate to improve long-term stability.
4.4. Materials and methods
4.4.1. Materials
Methylene Blue (MB) hydrate 96% and calcein were obtained from Acros Organic
(Pittsburgh, PA). Dioleoyl phosphatidylethanolamine (DOPE) was purchased from NOF
America (San Mateo, CA). All other chemical were purchased from Fisher Scientific (Pittsburgh,
PA) and used as received.
4.4.2. Detailed description of the synthesis
MB-DOPE: MB-EA-NP (433 mg, 0.806 mmol) was dissolved in anhydrous DCM and
added dropwise into DOPE (500 mg, 0.672 mmol) solution in 10 ml anhydrous DCM. The
reaction mixture was protected from light during the reaction and kept at room temperature for
24 hrs. The obtained organic phase was dried, evaporated under reduced pressure and subjected
to flash column chromatography using 100% ethyl acetate, and 100% methanol. The eluted
product solution was evaporated under reduced pressure yielding a light blue wax-like material
of MB-DOPE.
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Scheme 7. Synthetic scheme of MB-DOPE. Reagents and conditions: (1) MB-EA-NP, DOPE,
TEA, DCM, RT 24h. The synthesis MB-EA-NP has been previously described. 12
4.4.3. Preparation of liposome suspension
MB-DOPE (5-7 mg) was dissolved in CHCl3 (10 ml) in a 25 ml pear-shaped flask, and
the lipid solution was evaporated to a thin lipid film using a rotary evaporator. The films were
dried under vacuum for 1 hr and redissolved in pH 7.4 0.01 M phosphate buffer at a
concentration of 1 mg/ml. The solution was aged (30 min) at 50oC using a rotary evaporator
without vacuum, with occasional vortexing (10 min intervals). Subsequently, the liposome
suspensions were sonicated in a bath sonicator at 40oC for 5 mins. The liposome size was further
reduced by extrusion (5 times) at ambient temperature through a 100-nm pore Whatman
Nucleopore polycarbonate track-etched membrane using an Avanti® Mini-Extruder (Avanti
Polar Lipids, AL, USA). The buffer solutions were filtered through a 0.2 µm cellulose
membrane. Calcein-loaded liposomes were prepared using the afore-mentioned procedure,
except that the buffered solvent also contained dissolved calcein (5 x 10-2 M). After the
extrusion, the nonencapsulated fluorescent dyes were separated from the liposome-encapsulated
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dyes by dialysis. Specifically, liposome suspension was placed inside a Spectrapore® dialysis bag
with molecular cutoff of 3000 Da, and submerged in 1 L of pH 7.4 0.01 M phosphate buffer. The
dialysis procedure was carried-out for 2 days with 12-hr buffer change intervals. The resultant
stock calcein-loaded liposome suspension was withdrawn from the bag, and store at 2-4oC for up
to 2 days for further use. The purified calcein-loaded liposomes were diluted 100 times with
buffer to achieve an approximate lipid concentration of 10 µg/ml. The resultant suspensions were
separately treated with UV light and ˙OH to induce structural disruption of the liposome, thus
hypothetically release the calcein. The procedures for fluorescence measurements have been
previously described in section 2.3.3.
4.4.4. Procedures for light irradiation and reactive oxygen treatment
The detailed procedures for the UV light irradiation have been previously described in
section 2.5.2.12 The detailed procedures for the hydroxyl radical treatment have been previously
described in section 3.5.2 using hemoglobin as catalyst. 42
4.4.5. Dynamic light scattering measurements
The size and zeta potential of MB-DOPE liposomes were measured using a Zetasizer
Nano (Malvern Instruments, UK). All measurements were taken at 173o scattering angle at 25oC
using disposable polystyrene cuvettes and folded capillary cells. Temperature dependent
experiments were carried out in glass cuvettes, from 20 to 60oC with 10oC intervals. All
experiments were done in triplicate and the average value of z-average were reported.
4.4.6. Transmission electron microscopy
Liposome suspension images were taken using a Tecnai Spirit T12 (Thermo-Fisher)
coupled with Bio Sprint digital camera, operating at 80 kV and magnification of 6,500 to 15,000
times.
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APPENDIX A. 1H NMR spectra

Figure A1. 1H NMR spectrum of MB-NP in CDCl3.
Yield = 31%; 1H NMR (400 MHz, CDCl3) δ ppm: 8.24 (2H, d), 7.44 (2H, d), 7.37 (2H, d), 6.71
(2H, d), 6.64 (2H, d), 2.95 (12H, s)).

Figure A2.1H NMR spectrum of MB-ET in CDCl3.
Yield = 26%; 1H NMR (400 MHz, CDCl3) δ ppm: 7.34 (2H, d), 6.66 (2H, d), 6.62 (2H, d), 4.32
(2H, q), 4.24 (3H, t), s), 2.94 (12 H, s)).
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Figure A3. 1H NMR spectrum of MB-EA in CDCl3.
Yield = 75%; 1H NMR (400 MHz, CDCl3) δ ppm: 7.33 (2H, d), 6.70 (2H, d), 6.62 (2H, d), 5.40
(NH, s), 3.69 (2H, t), 3.36 (2H, q), 3.27 (OH, s), 2.94 (12 H, s).

Figure A4. 1H NMR spectrum of MB-PQ in CDCl3.
Yield = 85%; 1H NMR (400 MHz, CDCl3) δ ppm: 8.55 (1H, d), 7.95 (1H, d), 7.33 (2H, d), 7.30
(1H, t), 6.70 (2H, d), 6.59 (2H, d), 6.35 (1H, s), 6.30 (1H, s), 6.00 (1H, d), 4.99 (NH, s), 3.90
(3H, s), 3.64 (NH, s), 3.28 (2H, t), 2.94 (12H, s)).
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Figure A5. 1H NMR spectrum of MB-EA-NP in CDCl3.
Yield = 80%; 1H NMR (400 MHz, CDCl3) δ ppm: 8.25 (2H, d), 7.32 (2H, d), 7.28 (2H, d), 6.70
(2H, d), 6.63 (2H, d), 5.29 (NH, s), 4.34 (2H, t), 3.58 (2H, t), 2.94 (12H, s)).

Figure A6. 1H NMR spectrum of MB-EA-PQ in CDCl3.
Yield = 90%; 1H NMR (400 MHz, CDCl3) δ ppm: 8.55 (1H, d), 7.95 (1H, d), 7.33 (2H, d), 7.30
(1H, t), 6.70 (2H, d), 6.59 (2H, d), 6.35 (1H, s), 6.30 (1H, s), 6.00 (1H, d), 5.26 (2H, t), 4.99 (2H,
t), 4.75 (NH, s), 3.90 (3H, s), 3.64 (NH, s), 3.28 (2H, t), 2.94 (12H, s)).
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Figure A7. 1H NMR spectrum of MB-EA-ART in CDCl3.
Yield = 70%; 1H NMR (400 MHz, CDCl3) δ ppm: 7.40 (2H, d), 6.72 (4H, q), 5.76 (1H, d), 5.39
(1H, t), 5.29 (1H, t), 2.96 (12H, s)
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APPENDIX B. MS/MS SPECTRA
PQ MB

MB-EA

MB-EA-PQ

MB-PQ

Figure A8. Combined HPLC chromatograms of PQ, MB, MB-EA, MB-EA-PQ and MB-PQ (UV
265 nm).

Figure A9. (Top) MS/MS spectra and (bottom) MS spectra of MB-EA at 4.273 min retention
time.
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Figure A10. (Top) MS/MS spectra and (bottom) MS spectra of MB-EA-PQ at 6.824 min retention
time.

Figure A11. (Top) MS/MS spectra of MB-PQ and (bottom) MS spectra of MB-PQ at 7.325 min
retention time.
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APPENDIX C. FOURIER TRANSFORMED INFRA-RED SPECTRA
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Figure A12. ATR-FTIR spectra of MB-EA.
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Figure A13. ATR-FTIR spectra of MB-NP.
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Figure A14. ATR-FTIR spectra of MB-EA-PQ and MB-PQ.
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